Move over Big Pharma, Here Comes Silicon Valley Investment In Psychedelics Stocks Like Compass Pathways (CMPS)
Articles
Why Are Silicon Valley Billionaires Unicorn-Hunting In Psychedelics?
Move over Big Pharma, Here Comes Silicon Valley Investment In Psychedelics Stocks Like Compass Pathways (CMPS)
MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin
New research initiative will compare the efficacy of psilocybin with LSD.
Vermont finally OKs retail cannabis stores, years after legalizing
Nearly two years after legalizing the possession of marijuana for all adults, the Vermont legislature yesterday passed a bill that will finally allow the state’s first licensed retail cannabis stores to open no later than May 1, 2022.
New FDA Guidance Will Make It Easier To Approve CBD-Based Medicines
The Food and Drug Administration (FDA) is releasing new draft guidelines that are meant to streamline approvals for generic oral CBD medications.
Health Canada Authorization to Sell its Moonbeam Mushroom Products in Canada
Mind Cure's organic Moonbeam mushroom products are now eligible for sale in Canada.
COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares
Compass Pathways has closed its IPO financing, raising $146.6 million via the sale of 8,625,000 American Depository Shares.
Mind Cure Receives Health Canada Authorization to Sell its Moonbeam Mushroom Products in Canada
Mind Cure's organic Moonbeam mushroom products are now eligible for sale in Canada.
City Council Unanimously Votes To Decriminalize Psychedelics In Ann Arbor, Michigan
The Ann Arbor, Michigan City Council voted unanimously to decriminalize a wide range of psychedelics on Monday.
IPOs Drive Big Gains In Psychedelic Stocks
IPO fever is sweeping through the psychedelics space.
PharmaDrug Inc. Closes Transaction to Acquire First Smart Shop in the Netherlands, Initiates Major Push to Acquire Best of Breed High Traffic Locations
PharmaDrug will assume control of its first Super Smart psychedelics store on October 1st.
MindMed Catches Fire, Seeks To Up-List On NASDAQ
MindMed stock has spiked higher by over 30%, on big volume. New investor focus on the deepest clinical research program in the industry.
New Study Shows Rate of Ehlers-Danlos Syndrome Patients Treating Symptoms With Cannabis
New research out this month suggests that medical cannabis is extremely prevalent among patients looking to treat symptoms for a serious tissue disorder.
Psychedelics Stock Warrants Offer Interesting Leverage Play
Psychedelic stock warrants that are currently out of the money COULD produce big returns for investors.
Medical Cannabis Edibles Now Available In Florida
Medical cannabis edibles are now available in Florida, nearly four years after voters approved the reforms, the Orlando Sentinel reports